Range Low Price High Price Comment
30 days $3.30 $4.26 Thursday, 28th Mar 2024 ALIM stock ended at $3.90. During the day the stock fluctuated 6.65% from a day low at $3.76 to a day high of $4.01.
90 days $3.07 $4.38
52 weeks $1.56 $4.38

Historical Alimera Sciences prices

Date Open High Low Close Volume
2023-06-12 $2.91 $2.99 $2.78 $2.82 242 471
2023-06-09 $2.51 $2.61 $2.47 $2.50 88 159
2023-06-08 $2.75 $2.76 $2.52 $2.58 83 246
2023-06-07 $2.84 $2.86 $2.70 $2.72 56 929
2023-06-06 $2.85 $3.00 $2.66 $2.89 159 151
2023-06-05 $2.73 $2.93 $2.70 $2.86 160 976
2023-06-02 $2.69 $2.76 $2.59 $2.68 72 698
2023-06-01 $2.75 $2.75 $2.60 $2.61 64 790
2023-05-31 $2.64 $2.81 $2.61 $2.75 111 714
2023-05-30 $2.57 $2.65 $2.56 $2.65 138 931
2023-05-26 $2.62 $2.68 $2.50 $2.64 61 924
2023-05-25 $2.60 $2.67 $2.46 $2.58 160 387
2023-05-24 $2.33 $2.55 $2.27 $2.54 171 445
2023-05-23 $2.60 $2.69 $2.30 $2.35 417 043
2023-05-22 $2.30 $2.85 $2.28 $2.55 594 067
2023-05-19 $2.24 $2.41 $2.10 $2.30 1 099 841
2023-05-18 $2.68 $3.18 $2.36 $2.46 34 395 076
2023-05-17 $1.88 $2.08 $1.86 $2.06 31 388
2023-05-16 $1.68 $2.02 $1.65 $1.88 21 855
2023-05-15 $1.70 $1.76 $1.64 $1.64 7 920
2023-05-12 $1.75 $1.75 $1.56 $1.62 30 973
2023-05-11 $1.70 $1.73 $1.60 $1.68 14 821
2023-05-10 $1.72 $1.93 $1.57 $1.66 20 802
2023-05-09 $1.90 $1.90 $1.74 $1.74 8 392
2023-05-08 $1.90 $1.90 $1.80 $1.80 5 211
Click to get the best stock tips daily for free!

About Alimera Sciences

Alimera Sciences Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affectin... ALIM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT